The pharmaceutical industry has traditionally been a delicate balancing act between innovation, regulation, cost, and time. Yet today, this delicate balance has become unimaginable in its complexity. Rising research and development costs, increased compliance costs, growing global sourcing, and the need for faster time-to-market have prompted companies to rethink their traditional ways of doing business and develop new operational models.
At the core of this transformation are three powerful forces at work: active pharmaceutical ingredient (API) contract manufacturing companies, evolving pharma contract service providers, and the importance of comparator drugs and comparator drug sourcing.
By working together strategically, these three forces can create greater agility, reduce risk, and drive sustainable growth in the changing pharmaceutical landscape.
The New Pharma Reality: Complexity Meets Opportunity
The pharmaceutical industry today is not only about manufacturing drugs, but also about managing the entire ecosystem (raw material sourcing, clinical trials, regulatory submission, etc.) involved in developing a drug. Each phase requires precision, speed, and the ability to adapt to ever-changing circumstances.
A traditional model exists for developing new drugs. However, due to the complexity involved in developing drugs and the need for quicker development times, the traditional business model is being replaced by a partnership approach to provide services and develop a drug.
Pharmaceutical manufacturers cannot continue to develop drugs without collaboration through an ecosystem where strategic API contract manufacturers and specialised pharma contract manufacturers work together to achieve a goal.
Pharma Contract Companies: More Than Just Vendors
In the past, contract companies were thought to be purely outsourcing vehicles. However, today’s pharmaceutical contract companies have become true partners in innovation.
These organisations are the leading edge of:
- Regulatory expertise
- International scope and supply chain management capabilities
- Advanced data analysis competencies
- Therapeutic expertise in niche drug categories
The Emergence of Integrated Service Providers
Many of today’s pharmaceutical contract organisations provide complete and comprehensive solutions along the entire pharmaceutical product life cycle, including:
- API development and manufacturing
- Manufacturing of finished dosage forms
- Packaging and labeling
- Regulatory compliance
By integrating these services, the pharmaceutical industry as a whole can reduce the amount of fragmentation that existed before this shift and facilitate better coordination throughout the entire drug development lifecycle.
Strategic Advantage Through Collaboration
By choosing your partner wisely, you can achieve a strategic advantage that allows for:
- Faster time to market
- Improved quality of products
- Greater compliance across continents
Simply put, pharmaceutical companies are no longer just outsourcing; they are also co-creating value.
Comparator Drug & Comparator Drug Sourcing: The Silent Enabler of Clinical Success
Even though manufacturing is often regarded as the most important part of bringing new drugs to market, it is actually the clinical trials that show us whether a drug has clinical value. Within the overall scope of clinical trials, comparator drugs are one of the key pieces to proving this clinical value.
Why Comparator Drugs Matter?
Comparator drugs are approved drugs that are used to compare the safety and efficacy of a new drug.
Some of the critical questions comparator drugs help to answer during clinical trials include:
- Is the new drug more effective than the comparator drug?
- Does it have fewer adverse events than the comparator drug?
- How does the new drug compare to the current standard of care?
If there are no reliable comparator drugs, the context and credibility of clinical data are diminished.
What Challenges are Associated with Comparator Drug Sourcing?
Comparator drug sourcing is complicated by many issues, including:
- Availability of comparator drugs globally; not all drugs are available in all countries.
- Under regulatory limits, each country has its own sourcing guidelines and criteria.
- Improper oversight of supply chain risks, counterfeit products, delays in shipments and temperature sensitivity.
- Pricing pressure; procurement costs can be high for branded products.
What is Required for Effective Comparator Drug Sourcing?
Successful comparator drug sourcing requires:
- Global networks of suppliers.
- Regulatory expertise/insight.
- Quality control mechanisms.
- Real-time visibility into the supply chain.
Specialised partner companies as well as contract pharmaceutical companies are vital to successful comparator sourcing.
Bridging Manufacturing & Clinical Supply
Integration of manufacturing and clinical supply chains is one of today’s major trends in pharmaceutical companies. In the past, these two functions were done separately; however, companies have begun to see benefits by bringing them together.
How Does Integration Work?
The following is an example of how integration looks:
- Coordinated timelines between the production of active pharmaceutical ingredients (API) and clinical trials.
- Information can be shared via a unified data system to improve forecasting.
- Vendors are managed in a unified manner.
How Does This Benefit Companies?
- Reduction in delays
- Reduction in costs
- Improved outcomes from clinical trials
When API contract manufacturing is coordinated with the sourcing of comparator drugs, companies can build a more efficient, streamlined process from the development of the molecule through to commercial production.
Risk Mitigation in a Globalised Supply Chain
The scope of globalisation has created new opportunities, while at the same time, it has created an increased vulnerability to risk.
Global supply chains are regularly impacted by geopolitical challenges and pandemics.
Potential Risk Areas
- Single source dependency
- Regulatory compliance
- Logistics disruption
- Quality inconsistency
How Strategic Partnerships Can Assist
Working with experienced pharmaceutical contract companies to:
- Source product through multiple channels.
- Ensure regulatory compliance across countries/regions.
- Have a robust quality assurance program in place.
In addition, when it comes to comparator drugs, working with an expert on comparator drug sourcing can also provide ways to reduce the threat of purchasing counterfeit or inferior drugs due to the lack of regulations.
Technology As a Catalyst for Transformation
Digital tools are transforming all segments within pharma, including all components of the value chain, including manufacturing, sourcing, etc.
The following technologies will continue to revolutionise and change the Pharmaceutical industry:
- Predictive Analytics for Demand Forecasting – Predictive Analytics is Used for Demand Forecasting
- Supply Chain Transparency Via Blockchain
- Real-time Monitoring – IoT Enabled
- Process Optimisation Using Digital Twins
API Contract Manufacturing Will Experience:
- Increased Efficiency
- Reduced Batch Failure
- Improved Compliance Tracking
Comparator Drug Sourcing Will Experience:
- Better Supplier Verification
- Real-time Shipping Visibility
- Improved Document Accuracy
Human Expertise Is Not Replaced By Technology; Instead, It Is Enhanced.
Final Thoughts
It’s a complicated process to get from discovering a drug to getting it into patients’ hands. It should not be a chaotic endeavour.
Using API contract manufacturing in strategic ways, working with innovative pharmaceutical contract manufacturing organisations, and having a good command of the comparator drug and comparator drug sourcing will position pharmaceutical companies to achieve unprecedented levels of productivity, innovative product development, and product resiliency.
The winners in today’s marketplace will succeed by developing collaborative relationships, investing in intelligent sourcing techniques, and creating flexible systems that can adapt to the changing needs of their customers. The success of a pharmaceutical company’s future will depend on how well they deliver their products, not simply on the products themselves.
There’s no better time than today to begin making smarter decisions to pave the path to a more successful future.